{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:56:36Z","timestamp":1787871396722,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41423-018-0010-6","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:30:26Z","timestamp":1522809026000},"page":"367-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Mei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Sterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamal","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunde","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul, A. et al. Systemic lupus erythematosus. Nat. Rev. Dis. Prim. 2, 16039 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/ar3433","volume":"13","author":"T Dorner","year":"2011","unstructured":"Dorner, T., Giesecke, C. & Lipsky, P. E. Mechanisms of B cell autoimmunity in SLE. Arthritis Res. Ther. 13, 243 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1177\/0961203313509295","volume":"22","author":"B Duxbury","year":"2013","unstructured":"Duxbury, B., Combescure, C. & Chizzolini, C. Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis. Lupus 22, 1489\u20131503 (2013).","journal-title":"Lupus"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra, S. V. et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377, 721\u2013731 (2011).","journal-title":"Lancet"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/art.30613","volume":"63","author":"R Furie","year":"2011","unstructured":"Furie, R. et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 63, 3918\u20133930 (2011).","journal-title":"Arthritis Rheum."},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrrheum.2016.158","volume":"12","author":"T Dorner","year":"2016","unstructured":"Dorner, T. & Lipsky, P. E. Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE. Nat. Rev. Rheumatol. 12, 645\u2013657 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrrheum.2016.191","volume":"12","author":"I Sanz","year":"2016","unstructured":"Sanz, I. Systemic lupus erythematosus: extent and patterns of off-label use of rituximab for SLE. Nat. Rev. Rheumatol. 12, 700\u2013702 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/ard.2008.096495","volume":"69","author":"AM Jacobi","year":"2010","unstructured":"Jacobi, A. M. et al. HLA-DRhigh\/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 69, 305\u2013308 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/ar3042","volume":"12","author":"B Rodriguez-Bayona","year":"2010","unstructured":"Rodriguez-Bayona, B., Ramos-Amaya, A., Perez-Venegas, J. J., Rodriguez, C. & Brieva, J. A. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res. Ther. 12, R108 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/cmi.2016.47","volume":"14","author":"LD Zhao","year":"2017","unstructured":"Zhao, L. D. et al. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus. Cell. Mol. Immunol. 14, 842\u2013849 (2017).","journal-title":"Cell. Mol. Immunol."},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1172\/JCI24179","volume":"115","author":"A Cappione 3rd","year":"2005","unstructured":"Cappione, A. 3rd et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115, 3205\u20133216 (2005).","journal-title":"J. Clin. Invest."},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni.3175","volume":"16","author":"CM Tipton","year":"2015","unstructured":"Tipton, C. M. et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat. Immunol. 16, 755\u2013765 (2015).","journal-title":"Nat. Immunol."},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imr.12374","volume":"269","author":"AC Lino","year":"2016","unstructured":"Lino, A. C., Dorner, T., Bar-Or, A. & Fillatreau, S. Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases. Immunol. Rev. 269, 130\u2013144 (2016).","journal-title":"Immunol. Rev."},{"issue":"11","key":"10_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/cmi.2016.59","volume":"14","author":"Kyung-Ah Cho","year":"2017","unstructured":"Cho K. A., et al. Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner. Cell. Mol. Immunol. 14, 895\u2013908 (2017).","journal-title":"Cellular & Molecular Immunology"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s13075-014-0477-1","volume":"16","author":"J Sieber","year":"2014","unstructured":"Sieber, J. et al. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation. Arthritis Res. Ther. 16, 477 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow, M. K. Type I interferon in the pathogenesis of lupus. J. Immunol. 192, 5459\u20135468 (2014).","journal-title":"J. Immunol."},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","volume":"44","author":"M Menon","year":"2016","unstructured":"Menon, M., Blair, P. A., Isenberg, D. A. & Mauri, C. A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity 44, 683\u2013697 (2016).","journal-title":"Immunity"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/art.21031","volume":"52","author":"KA Kirou","year":"2005","unstructured":"Kirou, K. A. et al. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 52, 1491\u20131503 (2005).","journal-title":"Arthritis Rheum."},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/art.21890","volume":"54","author":"J Hua","year":"2006","unstructured":"Hua, J., Kirou, K., Lee, C. & Crow, M. K. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 54, 1906\u20131916 (2006).","journal-title":"Arthritis Rheum."},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.4049\/jimmunol.1302112","volume":"192","author":"A Palanichamy","year":"2014","unstructured":"Palanichamy, A. et al. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J. Immunol. 192, 906\u2013918 (2014).","journal-title":"J. Immunol."},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.4049\/jimmunol.181.9.5875","volume":"181","author":"MB Uccellini","year":"2008","unstructured":"Uccellini, M. B. et al. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J. Immunol. 181, 5875\u20135884 (2008).","journal-title":"J. Immunol."},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.4049\/jimmunol.174.7.4043","volume":"174","author":"IB Bekeredjian-Ding","year":"2005","unstructured":"Bekeredjian-Ding, I. B. et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 174, 4043\u20134050 (2005).","journal-title":"J. Immunol."},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/icb.2012.10","volume":"90","author":"K Kiefer","year":"2012","unstructured":"Kiefer, K., Oropallo, M. A., Cancro, M. P. & Marshak-Rothstein, A. Role of type I interferons in the activation of autoreactive B cells. Immunol. Cell Biol. 90, 498\u2013504 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","volume":"113","author":"C Wehr","year":"2004","unstructured":"Wehr, C. et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin. Immunol. 113, 161\u2013171 (2004).","journal-title":"Clin. Immunol."},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","volume":"105","author":"GP Sims","year":"2005","unstructured":"Sims, G. P. et al. Identification and characterization of circulating human transitional B cells. Blood 105, 4390\u20134398 (2005).","journal-title":"Blood"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.4049\/jimmunol.0803391","volume":"182","author":"J Lee","year":"2009","unstructured":"Lee, J., Kuchen, S., Fischer, R., Chang, S. & Lipsky, P. E. Identification and characterization of a human CD5+ pre-naive B cell population. J. Immunol. 182, 4116\u20134126 (2009).","journal-title":"J. Immunol."},{"key":"10_CR27","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman, D. D., Ibanez, D. & Urowitz, M. B. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 29, 288\u2013291 (2002).","journal-title":"J. Rheumatol."},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2249.2009.03880.x","volume":"156","author":"KO Kong","year":"2009","unstructured":"Kong, K. O. et al. Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus. Clin. Exp. Immunol. 156, 134\u2013140 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1038\/sj.onc.1204343","volume":"20","author":"M Bentires-Alj","year":"2001","unstructured":"Bentires-Alj, M. et al. Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines. Oncogene 20, 2805\u20132813 (2001).","journal-title":"Oncogene"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100, 2610\u20132615 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1006\/bbrc.2001.5025","volume":"284","author":"K Ruuth","year":"2001","unstructured":"Ruuth, K., Carlsson, L., Hallberg, B. & Lundgren, E. Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 284, 583\u2013586 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2010.02.012","volume":"263","author":"G Badr","year":"2010","unstructured":"Badr, G. et al. Type I interferon (IFN-alpha\/beta) rescues B-lymphocytes from apoptosis via PI3Kdelta\/Akt, Rho-A, NFkappaB and Bcl-2\/Bcl(XL). Cell. Immunol. 263, 31\u201340 (2010).","journal-title":"Cell. Immunol."},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2015.01.009","volume":"58","author":"NH Chang","year":"2015","unstructured":"Chang, N. H. et al. Interferon-alpha induces altered transitional B cell signaling and function in systemic lupus erythematosus. J. Autoimmun. 58, 100\u2013110 (2015).","journal-title":"J. Autoimmun."},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"13631","DOI":"10.1073\/pnas.250477397","volume":"97","author":"CH Yang","year":"2000","unstructured":"Yang, C. H. et al. IFNalpha\/beta promotes cell survival by activating NF-kappa B. Proc. Natl. Acad. Sci. USA 97, 13631\u201313636 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","volume":"192","author":"M Batten","year":"2000","unstructured":"Batten, M. et al. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192, 1453\u20131466 (2000).","journal-title":"J. Exp. Med."},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.4049\/jimmunol.1001708","volume":"185","author":"SL Rowland","year":"2010","unstructured":"Rowland, S. L., Leahy, K. F., Halverson, R., Torres, R. M. & Pelanda, R. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling. J. Immunol. 185, 4570\u20134581 (2010).","journal-title":"J. Immunol."},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood-2007-03-077222","volume":"111","author":"RT Woodland","year":"2008","unstructured":"Woodland, R. T. et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111, 750\u2013760 (2008).","journal-title":"Blood"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/cmi.2012.63","volume":"10","author":"X Zhang","year":"2013","unstructured":"Zhang, X. Regulatory functions of innate-like B cells. Cell. Mol. Immunol. 10, 113\u2013121 (2013).","journal-title":"Cell. Mol. Immunol."},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1136\/ard.2011.153312","volume":"70","author":"L Yeo","year":"2011","unstructured":"Yeo, L. et al. Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann. Rheum. Dis. 70, 2022\u20132028 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"e0128269","DOI":"10.1371\/journal.pone.0128269","volume":"10","author":"DG Adlowitz","year":"2015","unstructured":"Adlowitz, D. G. et al. Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response. PLoS ONE 10, e0128269 (2015).","journal-title":"PLoS ONE"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","volume":"209","author":"TA Barr","year":"2012","unstructured":"Barr, T. A. et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209, 1001\u20131010 (2012).","journal-title":"J. Exp. Med."},{"key":"10_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13075-015-0686-2","volume":"17","author":"V Fleischer","year":"2015","unstructured":"Fleischer, V. et al. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-alpha, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients. Arthritis Res. Ther. 17, 185 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"10_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair, P. A. et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32, 129\u2013140 (2010).","journal-title":"Immunity"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"173ra123","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-Borja","year":"2013","unstructured":"Flores-Borja, F. et al. CD19+ CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 5, 173ra123 (2013).","journal-title":"Sci. Transl. Med."},{"key":"10_CR45","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/art.38666","volume":"66","author":"CI Daien","year":"2014","unstructured":"Daien, C. I. et al. Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheumatol. 66, 2037\u20132046 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/096120339600500603","volume":"5","author":"E Peterson","year":"1996","unstructured":"Peterson, E., Robertson, A. D. & Emlen, W. Serum and urinary interleukin-6 in systemic lupus erythematosus. Lupus 5, 571\u2013575 (1996).","journal-title":"Lupus"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1191\/0961203304lu1023oa","volume":"13","author":"E Tackey","year":"2004","unstructured":"Tackey, E., Lipsky, P. E. & Illei, G. G. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus 13, 339\u2013343 (2004).","journal-title":"Lupus"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/art.39722","volume":"68","author":"BH Rovin","year":"2016","unstructured":"Rovin, B. H. et al. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of treatment with sirukumab (CNTO 136) in patients with active lupus nephritis. Arthritis Rheumatol. 68, 2174\u20132183 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/annrheumdis-2016-209668","volume":"76","author":"DJ Wallace","year":"2017","unstructured":"Wallace, D. J. et al. Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial. Ann. Rheum. Dis. 76, 534\u2013542 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.27221","volume":"62","author":"GG Illei","year":"2010","unstructured":"Illei, G. G. et al. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum. 62, 542\u2013552 (2010).","journal-title":"Arthritis Rheum."},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei, C. et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178, 6624\u20136633 (2007).","journal-title":"J. Immunol."},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1002\/art.38854","volume":"66","author":"SJ Fleischer","year":"2014","unstructured":"Fleischer, S. J. et al. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus. Arthritis Rheumatol. 66, 3424\u20133435 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.trsl.2014.10.005","volume":"165","author":"MK Crow","year":"2015","unstructured":"Crow, M. K., Olferiev, M. & Kirou, K. A. Targeting of type I interferon in systemic autoimmune diseases. Transl. Res. J. Lab. Clin. Med. 165, 296\u2013305 (2015).","journal-title":"Transl. Res. J. Lab. Clin. Med."}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0010-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0010-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0010-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:38Z","timestamp":1684617638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-018-0010-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10"],"URL":"https:\/\/doi.org\/10.1038\/s41423-018-0010-6","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"11 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}